← Open Payments lookup

SUZANNE GREGG: Open Payments

NPI 1710369103 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,341 in 162 payments from 12 companies in 2025. Trend: 2023 $1,879 · 2024 $1,839 · 2025 $2,341

Food & beverage: $2,341
CompanyPaymentsAmount
Alkermes, Inc.23$338
Otsuka America Pharmaceutical, Inc.28$305
ABBVIE INC.20$304
E.R. Squibb & Sons, L.L.C.20$263
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$253
Teva Pharmaceuticals USA, Inc.22$249
Neurocrine BioSciences, Inc.14$208
Axsome Therapeutics, Inc.6$173
Janssen Pharmaceuticals, Inc11$143
Takeda Pharmaceuticals U.S.A., Inc.3$52

Products named: ARISTADA, VRAYLAR, COBENFY, CAPLYTA, INGREZZA, REXULTI, Auvelity, AUSTEDO XR.

Industry payments across NE — which companies pay providers there.